Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 18.25
-0.59 (-3.13%)
Apr 21, 2026, 3:04 PM CST
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 9.83 billion as of April 21, 2026. Its market cap has increased by 130.72% in one year.
Market Cap
9.83B
Enterprise Value
10.94B
Revenue
1.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.25
Market Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 9.83B, an increase of 518.35%. That is a compound annual growth rate of 19.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 9.83B | 20.78% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.51B |
| Chongqing Genrix Biopharmaceutical | 11.41B |
| Aurisco Pharmaceutical | 11.19B |
| Beijing Hotgen Biotech | 10.92B |
| HitGen | 10.75B |
| Liaoning Chengda Biotechnology | 10.03B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.67B |
| Bio-Thera Solutions | 9.54B |